相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Antimicrobial susceptibility of extended-spectrum β-lactamase producers and multidrug-resistant Acinetobacter baumannii throughout the United States and comparative in vitro activity of tigecycline, a new glycylcycline antimicrobial
Daryl J. Hoban et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2007)
Comparative activities of cefepime and piperacillin/tazobactam tested against a global collection of Escherichia coli and Klebsiella spp. with an ESBL phenotype
Helio S. Sader et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2007)
Use of cefepime for the treatment of infections caused by extended spectrum β-lactamase-producing Klebsiella pneumoniae and Escherichia coli
Vincent J. LaBombardi et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2006)
Phenotypic and genotypic detection of ESBL mediated cephalosporin resistance in Klebsiella pneumoniae:: Emergence of high resistance against cefepime, the fourth generation cephalosporin
S. S. Grover et al.
JOURNAL OF INFECTION (2006)
Prevalence of newer β-lactamases in gram-negative clinical isolates collected in the United States from 2001 to 2002
Ellen S. Moland et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2006)
Extended-spectrum β-lactamases and clinical outcomes:: Current data
R Ramphal et al.
CLINICAL INFECTIOUS DISEASES (2006)
Clinical implications of extended spectrum β-lactamase (ESBL) producing Klebsiella species and Escherichia coli on cefepime effectiveness
S Kotapati et al.
JOURNAL OF INFECTION (2005)
Failure of cefepime therapy in treatment of Klebsiella pneumoniae bacteremia
W Song et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2005)
Pharmacodynamics of intermittent and continuous infusion piperacillin/tazobactam and cefepime against extended-spectrum β-lactamase-producing organisms
AM Reese et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2005)
Antibiotic therapy for Klebsiella pneumoniae bacteremia:: Implications of production of extended-spectrum β-lactamases
DL Paterson et al.
CLINICAL INFECTIOUS DISEASES (2004)
Pharmacokinetics-pharmacodynamics of cefepime and piperacillin-tazobactam against Escherichia coli and Klebsiella pneumoniae strains producing extended-spectrum β-lactamases:: Report from the ARREST program
PG Ambrose et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
Global epidemiology of antimicrobial resistance among community-acquired and nosocomial pathogens: A five-year summary from the SENTRY Antimicrobial Surveillance Program (1997-2001)
RN Jones
SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE (2003)
Sustained activity and spectrum of selected extended-spectrum beta-lactams (carbapenems and cefepime) against Enterobacter spp. and ESBL-producing Klebsiella spp.: report from the SENTRY antimicrobial surveillance program (USA, 1997-2000)
RN Jones et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2003)
Cefepime, piperacillin-tazobactam, and the inoculum effect in tests with extended-spectrum β-lactamase-producing Enterobacteriaceae
KS Thomson et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2001)
Extended-spectrum β-lactamases in the 21st century:: Characterization, epidemiology, and detection of this important resistance threat
PA Bradford
CLINICAL MICROBIOLOGY REVIEWS (2001)
Extended-spectrum β-lactamases:: Epidemiology, detection, and treatment
S Nathisuwan et al.
PHARMACOTHERAPY (2001)
Therapeutic challenges associated with extended-spectrum, β-lactamase-producing Escherichia coli and Klebsiella pneumoniae
A Wong-Beringer
PHARMACOTHERAPY (2001)
分享论文
